10 20 30 40 50 60 70 80 1N0W - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER GENE REGULATION/ANTITUMOR PROTEIN 15-OCT-02 1N0W
TITLE CRYSTAL STRUCTURE OF A RAD51-BRCA2 BRC REPEAT COMPLEX
COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA REPAIR PROTEIN RAD51 HOMOLOG 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ATPASE DOMAIN; COMPND 5 SYNONYM: RAD51, HRAD51, HSRAD51; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: BREAST CANCER TYPE 2 SUSCEPTIBILITY PROTEIN; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: BRC REPEAT TYPE 4; COMPND 11 SYNONYM: BRCA2 BRC4 REPEAT SEQUENCE; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: PEPTIDE LINKER; COMPND 15 CHAIN: L; COMPND 16 ENGINEERED: YES; COMPND 17 OTHER_DETAILS: THIS PEPTIDE LINKS THE BRCA2 TO THE RAD51; COMPND 18 MOL_ID: 4; COMPND 19 MOLECULE: ARTIFICIAL GLY-SER-MSE-GLY PEPTIDE; COMPND 20 CHAIN: C; COMPND 21 ENGINEERED: YES; COMPND 22 OTHER_DETAILS: THIS PEPTIDE COMES FROM THE EXPRESSION COMPND 23 VECTOR AND IS LINKED TO THE N-TERMINUS OF BRCA2
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RAD51; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGAT3; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: BRCA2; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PGAT3; SOURCE 21 MOL_ID: 3; SOURCE 22 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 23 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 24 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 25 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 26 EXPRESSION_SYSTEM_PLASMID: PGAT3; SOURCE 27 MOL_ID: 4; SOURCE 28 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 29 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 30 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 31 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 32 EXPRESSION_SYSTEM_PLASMID: PGAT3
KEYWDS DNA REPAIR, HOMOLOGOUS RECOMBINATION, BREAST CANCER KEYWDS 2 SUSCEPTIBILITY, RECA-LIKE ATPASE, PROTEIN COMPLEX, GENE KEYWDS 3 REGULATION/ANTITUMOR PROTEIN COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR L.PELLEGRINI,D.S.YU,T.LO,S.ANAND,M.LEE,T.L.BLUNDELL, AUTHOR 2 A.R.VENKITARAMAN
REVDAT 3 24-FEB-09 1N0W 1 VERSN REVDAT 2 05-AUG-03 1N0W 1 REMARK REVDAT 1 27-NOV-02 1N0W 0
JRNL AUTH L.PELLEGRINI,D.S.YU,T.LO,S.ANAND,M.LEE, JRNL AUTH 2 T.L.BLUNDELL,A.R.VENKITARAMAN JRNL TITL INSIGHTS INTO DNA RECOMBINATION FROM THE STRUCTURE JRNL TITL 2 OF A RAD51-BRCA2 COMPLEX JRNL REF NATURE V. 420 287 2002 JRNL REFN ISSN 0028-0836 JRNL PMID 12442171 JRNL DOI 10.1038/NATURE01230
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.85 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 0.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 55746 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1529 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1956 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 247 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.23 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURE WAS REFINED AGAINST REMARK 3 THE PEAK SE K EDGE WAVELENGTH DATASET. SELENOMETHIONINE REMARK 3 RESIDUES (RESIDUE NAME MSE) WERE USED IN THE REFINEMENT, AND REMARK 3 ARE PRESENT IN THE DEPOSITED COORDINATE FILE. FREIDEL PAIRS REMARK 3 WERE USED.
REMARK 4 REMARK 4 1N0W COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-OCT-02. REMARK 100 THE RCSB ID CODE IS RCSB017380.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-APR-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792, 0.90831 REMARK 200 MONOCHROMATOR : CHANNEL - CUT SI REMARK 200 MONOCHROMATOR + CYLINDRICAL REMARK 200 GRAZING INCIDENCE MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55746 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 24.850 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : 0.07700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.32100 REMARK 200 R SYM FOR SHELL (I) : 0.32100 REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: FREIDEL PAIRS WERE USED.
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: ETHYLENE GLYCOL, PH 7.2, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.65000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.60000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.57000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 38.60000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.65000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.57000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS ONE BIOLOGICAL UNIT, REMARK 300 CONSTITUTED BY ONE CHAIN A, ONE CHAIN B AND ONE CHAIN C
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, L, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 97 REMARK 465 THR A 230 REMARK 465 ASP A 231 REMARK 465 TYR A 232 REMARK 465 SER A 233 REMARK 465 GLY A 234 REMARK 465 ARG A 235 REMARK 465 GLY A 236 REMARK 465 GLN A 268 REMARK 465 VAL A 269 REMARK 465 VAL A 270 REMARK 465 ALA A 271 REMARK 465 GLN A 272 REMARK 465 VAL A 273 REMARK 465 ASP A 274 REMARK 465 GLY A 275 REMARK 465 ALA A 276 REMARK 465 ALA A 277 REMARK 465 MSE A 278 REMARK 465 PHE A 279 REMARK 465 ALA A 280 REMARK 465 ALA A 281 REMARK 465 ASP A 282 REMARK 465 PRO A 283 REMARK 465 LYS A 284 REMARK 465 LYS A 285 REMARK 465 PRO A 286 REMARK 465 ILE A 287 REMARK 465 GLY A 288 REMARK 465 GLY A 289 REMARK 465 ASN A 290 REMARK 465 ILE A 291 REMARK 465 ILE A 292 REMARK 465 LYS B 1517 REMARK 465 GLU B 1518 REMARK 465 THR L 1543 REMARK 465 GLY L 1544 REMARK 465 SER L 1545 REMARK 465 THR L 1546 REMARK 465 GLY L 1547 REMARK 465 SER L 1548 REMARK 465 THR L 1549 REMARK 465 GLY L 1550 REMARK 465 SER L 1551 REMARK 465 MSE L 1555 REMARK 465 GLY L 1556
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 130 -11.93 92.27 REMARK 500 TYR A 315 -169.36 -114.56 REMARK 500 ASP A 316 86.64 9.71 REMARK 500 PRO A 318 -14.17 -48.20 REMARK 500 GLU B1548 61.56 -118.93 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 633 DISTANCE = 6.26 ANGSTROMS REMARK 525 HOH A 706 DISTANCE = 5.51 ANGSTROMS
REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 401 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLN A 101 OE1 REMARK 620 2 HOH A 553 O 146.6 REMARK 620 3 LEU A 113 O 109.6 91.6 REMARK 620 4 GLY A 116 O 92.1 105.3 109.1 REMARK 620 5 HOH A 646 O 80.6 73.7 89.9 161.0 REMARK 620 N 1 2 3 4
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 401 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 501 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 502 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 503 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 504 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 505 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 506
REMARK 999 REMARK 999 SEQUENCE REMARK 999 ALL CHAINS REMARK 999 IN THE ENTRY ARE PART OF AN ENGINEERED, REMARK 999 CHIMERIC PROTEIN CONSTRUCT. IN THE CONSTRUCT, REMARK 999 THE AMINO-TO-CARBOXYL ORDER OF THE CHAINS IS: C-B-L-A. REMARK 999 CHAIN C IS A GSMG SEQUENCE THAT COMES FROM REMARK 999 THE EXPRESSION VECTOR, B IS THE BRCA2 BRC REPEAT, REMARK 999 L IS THE TGSTGSTGSTGSMG SEQUENCE LINKING CHAINS REMARK 999 B AND A, AND CHAIN A IS THE RAD51 ATPASE DOMAIN. REMARK 999 CHAIN C APPEARS AS A SEPARATE ENTITY BECAUSE THE REMARK 999 TWO INITIAL RESIDUES OF CHAIN B, 1517-8, ARE NOT REMARK 999 VISIBLE IN THE DENSITY MAP. LIKEWISE, THE LINKER REMARK 999 IS NOT VISIBLE IN THE DENSITY MAP, WITH THE REMARK 999 EXCEPTION OF THE FIRST THREE RESIDUES:TGS.
DBREF 1N0W A 97 339 UNP Q06609 RAD51_HUMAN 97 339 DBREF 1N0W B 1517 1551 UNP P51587 BRCA2_HUMAN 1517 1551 DBREF 1N0W L 1543 1556 PDB 1N0W 1N0W 1543 1556 DBREF 1N0W C 1 4 PDB 1N0W 1N0W 1 4
SEQADV 1N0W MSE A 125 UNP Q06609 MET 125 MODIFIED RESIDUE SEQADV 1N0W MSE A 158 UNP Q06609 MET 158 MODIFIED RESIDUE SEQADV 1N0W MSE A 210 UNP Q06609 MET 210 MODIFIED RESIDUE SEQADV 1N0W MSE A 211 UNP Q06609 MET 211 MODIFIED RESIDUE SEQADV 1N0W MSE A 243 UNP Q06609 MET 243 MODIFIED RESIDUE SEQADV 1N0W MSE A 251 UNP Q06609 MET 251 MODIFIED RESIDUE SEQADV 1N0W MSE A 278 UNP Q06609 MET 278 MODIFIED RESIDUE SEQADV 1N0W MSE A 326 UNP Q06609 MET 326 MODIFIED RESIDUE
SEQRES 1 A 243 SER GLU ILE ILE GLN ILE THR THR GLY SER LYS GLU LEU SEQRES 2 A 243 ASP LYS LEU LEU GLN GLY GLY ILE GLU THR GLY SER ILE SEQRES 3 A 243 THR GLU MSE PHE GLY GLU PHE ARG THR GLY LYS THR GLN SEQRES 4 A 243 ILE CYS HIS THR LEU ALA VAL THR CYS GLN LEU PRO ILE SEQRES 5 A 243 ASP ARG GLY GLY GLY GLU GLY LYS ALA MSE TYR ILE ASP SEQRES 6 A 243 THR GLU GLY THR PHE ARG PRO GLU ARG LEU LEU ALA VAL SEQRES 7 A 243 ALA GLU ARG TYR GLY LEU SER GLY SER ASP VAL LEU ASP SEQRES 8 A 243 ASN VAL ALA TYR ALA ARG ALA PHE ASN THR ASP HIS GLN SEQRES 9 A 243 THR GLN LEU LEU TYR GLN ALA SER ALA MSE MSE VAL GLU SEQRES 10 A 243 SER ARG TYR ALA LEU LEU ILE VAL ASP SER ALA THR ALA SEQRES 11 A 243 LEU TYR ARG THR ASP TYR SER GLY ARG GLY GLU LEU SER SEQRES 12 A 243 ALA ARG GLN MSE HIS LEU ALA ARG PHE LEU ARG MSE LEU SEQRES 13 A 243 LEU ARG LEU ALA ASP GLU PHE GLY VAL ALA VAL VAL ILE SEQRES 14 A 243 THR ASN GLN VAL VAL ALA GLN VAL ASP GLY ALA ALA MSE SEQRES 15 A 243 PHE ALA ALA ASP PRO LYS LYS PRO ILE GLY GLY ASN ILE SEQRES 16 A 243 ILE ALA HIS ALA SER THR THR ARG LEU TYR LEU ARG LYS SEQRES 17 A 243 GLY ARG GLY GLU THR ARG ILE CYS LYS ILE TYR ASP SER SEQRES 18 A 243 PRO CYS LEU PRO GLU ALA GLU ALA MSE PHE ALA ILE ASN SEQRES 19 A 243 ALA ASP GLY VAL GLY ASP ALA LYS ASP SEQRES 1 B 35 LYS GLU PRO THR LEU LEU GLY PHE HIS THR ALA SER GLY SEQRES 2 B 35 LYS LYS VAL LYS ILE ALA LYS GLU SER LEU ASP LYS VAL SEQRES 3 B 35 LYS ASN LEU PHE ASP GLU LYS GLU GLN SEQRES 1 L 14 THR GLY SER THR GLY SER THR GLY SER THR GLY SER MSE SEQRES 2 L 14 GLY SEQRES 1 C 4 GLY SER MSE GLY
MODRES 1N0W MSE A 125 MET SELENOMETHIONINE MODRES 1N0W MSE A 158 MET SELENOMETHIONINE MODRES 1N0W MSE A 210 MET SELENOMETHIONINE MODRES 1N0W MSE A 211 MET SELENOMETHIONINE MODRES 1N0W MSE A 243 MET SELENOMETHIONINE MODRES 1N0W MSE A 251 MET SELENOMETHIONINE MODRES 1N0W MSE A 326 MET SELENOMETHIONINE MODRES 1N0W MSE C 3 MET SELENOMETHIONINE
HET MSE A 125 8 HET MSE A 158 16 HET MSE A 210 8 HET MSE A 211 8 HET MSE A 243 8 HET MSE A 251 8 HET MSE A 326 16 HET MSE C 3 8 HET MG A 401 1 HET CL A 501 1 HET EDO A 502 4 HET EDO A 503 4 HET EDO A 504 4 HET EDO A 505 4 HET EDO A 506 4
HETNAM MSE SELENOMETHIONINE HETNAM MG MAGNESIUM ION HETNAM CL CHLORIDE ION HETNAM EDO 1,2-ETHANEDIOL
HETSYN EDO ETHYLENE GLYCOL
FORMUL 1 MSE 8(C5 H11 N O2 SE) FORMUL 5 MG MG 2+ FORMUL 6 CL CL 1- FORMUL 7 EDO 5(C2 H6 O2) FORMUL 12 HOH *247(H2 O)
HELIX 1 1 SER A 106 LEU A 113 1 8 HELIX 2 2 GLY A 132 CYS A 144 1 13 HELIX 3 3 GLN A 145 LEU A 146 5 2 HELIX 4 4 PRO A 147 GLY A 151 5 5 HELIX 5 5 ARG A 167 TYR A 178 1 12 HELIX 6 6 SER A 181 ASN A 188 1 8 HELIX 7 7 ASN A 196 SER A 214 1 19 HELIX 8 8 THR A 225 ARG A 229 5 5 HELIX 9 9 GLU A 237 GLY A 260 1 24 HELIX 10 10 PRO B 1519 GLY B 1523 5 5 HELIX 11 11 ALA B 1535 VAL B 1542 1 8
SHEET 1 A 2 GLN A 101 ILE A 102 0 SHEET 2 A 2 ILE A 117 GLU A 118 -1 O ILE A 117 N ILE A 102 SHEET 1 B10 GLY A 333 GLY A 335 0 SHEET 2 B10 ALA A 323 ASN A 330 -1 N ALA A 328 O GLY A 335 SHEET 3 B10 THR A 309 ILE A 314 -1 N ARG A 310 O PHE A 327 SHEET 4 B10 THR A 298 LYS A 304 -1 N TYR A 301 O LYS A 313 SHEET 5 B10 ILE A 122 PHE A 126 1 N PHE A 126 O LEU A 300 SHEET 6 B10 ALA A 262 ASN A 267 1 O ILE A 265 N MSE A 125 SHEET 7 B10 TYR A 216 ASP A 222 1 N LEU A 219 O VAL A 264 SHEET 8 B10 LYS A 156 ASP A 161 1 N ILE A 160 O ILE A 220 SHEET 9 B10 VAL A 189 ARG A 193 1 O ALA A 190 N TYR A 159 SHEET 10 B10 HIS B1525 THR B1526 -1 O HIS B1525 N TYR A 191
LINK C GLN B1551 N THR L 1 1555 1555 1.33 LINK C GLU A 124 N MSE A 125 1555 1555 1.33 LINK C MSE A 125 N PHE A 126 1555 1555 1.33 LINK C ALA A 157 N AMSE A 158 1555 1555 1.32 LINK C ALA A 157 N BMSE A 158 1555 1555 1.33 LINK C AMSE A 158 N TYR A 159 1555 1555 1.33 LINK C BMSE A 158 N TYR A 159 1555 1555 1.33 LINK C ALA A 209 N MSE A 210 1555 1555 1.33 LINK C MSE A 210 N MSE A 211 1555 1555 1.33 LINK C MSE A 211 N VAL A 212 1555 1555 1.33 LINK C GLN A 242 N MSE A 243 1555 1555 1.33 LINK C MSE A 243 N HIS A 244 1555 1555 1.33 LINK C ARG A 250 N MSE A 251 1555 1555 1.33 LINK C MSE A 251 N LEU A 252 1555 1555 1.33 LINK C ALA A 325 N BMSE A 326 1555 1555 1.33 LINK C ALA A 325 N AMSE A 326 1555 1555 1.33 LINK C BMSE A 326 N PHE A 327 1555 1555 1.33 LINK C AMSE A 326 N PHE A 327 1555 1555 1.33 LINK MG MG A 401 OE1 GLN A 101 1555 1555 2.27 LINK MG MG A 401 O HOH A 553 1555 1555 2.32 LINK MG MG A 401 O LEU A 113 1555 1555 2.24 LINK MG MG A 401 O GLY A 116 1555 1555 1.90 LINK MG MG A 401 O HOH A 646 1555 1555 2.22 LINK C SER C 2 N MSE C 3 1555 1555 1.33 LINK C MSE C 3 N GLY C 4 1555 1555 1.33
CISPEP 1 ASP A 222 SER A 223 0 1.13
SITE 1 AC1 5 GLN A 101 LEU A 113 GLY A 116 HOH A 553 SITE 2 AC1 5 HOH A 646 SITE 1 AC2 5 ARG A 130 GLY A 132 LYS A 133 THR A 134 SITE 2 AC2 5 GLN A 135 SITE 1 AC3 5 GLU A 154 ALA A 246 HOH A 516 HOH A 536 SITE 2 AC3 5 HOH A 689 SITE 1 AC4 5 GLU A 124 LEU A 249 ALA A 293 ARG A 299 SITE 2 AC4 5 HOH A 528 SITE 1 AC5 5 ILE A 311 GLU A 324 MSE A 326 HOH A 694 SITE 2 AC5 5 HOH A 695 SITE 1 AC6 4 THR A 162 GLU A 163 ALA A 226 LEU A 227 SITE 1 AC7 5 GLN A 135 THR A 165 ARG A 170 PRO A 318 SITE 2 AC7 5 CYS A 319
CRYST1 57.300 59.140 77.200 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017452 0.000000 0.000000 0.00000
SCALE2 0.000000 0.016909 0.000000 0.00000
SCALE3 0.000000 0.000000 0.012953 0.00000